Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpts.com
ENDPOINTS NEWS
Get the latest updates from ENDPOINTS NEWS directly as they happen.
Follow now 172 followers
Latest posts
Last updated about 10 hours ago
340B sales grew 23% last year, and court battle over pilot program intensifies
about 10 hours ago
Eligible health centers purchased $81.4 billion in discounted drugs under the federal...
Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources say
about 11 hours ago
An FDA staff analysis of the safety of pediatric Covid-19 shots has...
A 2-speed payer transformation is underway
about 14 hours ago
Health insurers are facing two colliding forces heading into 2026: Medical costs...
CHMP calls to reject Anavex Alzheimer’s pill over impurities, side effects and weak efficacy
about 14 hours ago
As part of a batch of recommendations issued Friday, the European Medicines...
#SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
about 15 hours ago
Roche and BioNTech stole the show at this year’s San Antonio Breast...
Arcus, Gilead report Phase 3 TIGIT failure in upper GI cancers
about 15 hours ago
Another TIGIT program has failed in the clinic, this time in a...
Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor
about 17 hours ago
Plus, news about BioCryst, Cycle Pharma, Applied Therapeutics, Contineum Therapeutics, Juncell Therapeutics...
GSK spins out corporate VC fund focused on bioelectronic tech
about 17 hours ago
GSK has offloaded a corporate venture unit that invests in bioelectronic startups...
Tenaya targets $60M offering after heart disease pipeline updates
about 19 hours ago
Tenaya Therapeutics, a company focused on developing gene therapies for heart conditions...
FDA broadens label for Amgen's Uplizna as it enters rare disease competition
about 19 hours ago
The FDA on Thursday expanded the label for Amgen’s rare disease drug...
Centessa CEO to step down; John Maraganore, Clive Meanwell find CMO for their new cardio bet
about 19 hours ago
→ Centessa Pharmaceuticals president Mario Alberto Accardi will take over as CEO...
CDC report underscores benefit of Covid-19 vaccines in kids
1 day ago
A new CDC report highlights the benefit of the Covid-19 vaccines at...